Plasma is a strategic resource-Reference-Cited by-同舟云学术

Plasma is a strategic resource

Published:2016-11-12 Issue:12 Volume:56 Page:3133-3137
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Strengers Paul F.W.¹²,Klein Harvey G.³

Affiliation:

1. Sanquin Plasma Products; Amsterdam the Netherlands

2. International Plasma Fractionation Association, The Netherlands; Amsterdam The Netherlands

3. Department of Transfusion Medicine, Clinical Center; National Institutes of Health; Bethesda Maryland

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13913/fullpdf

Reference25 articles.

1. Should blood be an essential medicine;Klein;N Engl J Med,2013

2. http://www.who.int/medicines/publications/

3. A randomized trial of Factor VIII and neutralizing antibodies in hemophilia A;Peyvandi;N Engl J Med,2016

4. Risks of inhibitors to recombinant Factor VIII: a quarter of a century to reach the conclusion;Burnouf;J Thromb Haemost,2016

5. Improving access to safe blood products through local production and technology transfer in blood establishment [Internet] http://www.who.int/phi/publications/blood-prods_technology_transfer.pdf

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of Indian National plasma policy at blood bank of a tertiary care hospital: A step towards strengthening of blood transfusion services;Transfusion Clinique et Biologique;2024-02

2. Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled study;Frontiers in Neuroscience;2024-02-01

3. The availability of plasma donors and plasma: A sociologist's perspective;Vox Sanguinis;2024-01-16

4. Safeguarding plasma for fractionation: How can we deal with operational challenges in European Union countries;Vox Sanguinis;2023-11-20

5. Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries;Vox Sanguinis;2023-10-23